Phase 2 Study of MD-1100 Acetate on Gastrointestinal Transit in Patients With C-IBS

Clinical trial NCT00258193 · COMPLETED

Trial details

NCT number: NCT00258193
Sponsor: Ironwood Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Irritable Bowel Syndrome

Start date: 2006-01-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.